Novel Coronavirus Pneumonia 15-Minute Serum Quick Test

In 15 minutes, the serum can be used to detect whether the blood contains antibodies to novel coronavirus pneumonia. Greatly save the detection time and improve the detection efficiency.

On the morning of April 14th, the press conference of "the successful development of the world's first novel coronavirus pneumonia immune detection and intelligent analysis system based on 5G cloud computing" was held in Chengdu.

The system can provide pandemic investigation and pandemic monitoring and early warning public health management platforms for disease control and supervision agencies. It can implement self-testing, automatic uploading of test results, automatic identification of suspected patients, self-positioning of suspected patients, continuous tracking of suspected patients, etc. It was found that early treatment, early prevention, and early isolation minimized the cost of medical treatment and social and economic losses,

It is understood that  novel coronavirus pneumonia immune detection and intelligent analysis system is led by Sichuan University and jointly developed by the enterprise. High-tech products, in different scenarios (airport / station security screening, large-scale event security screening, community and personal self-checking, etc.), carry out immune testing on the target population, and analyze it through artificial intelligence technology, without the need for professional diagnosis by a doctor. The target population can hold the hardware terminal, which is as convenient and fast as the use of electronic products. It does not require special processing of the sample and no instrument. Using 1 drop of serum / plasma can complete all tests within 15 minutes, which can provide epidemic information for disease control regulatory agencies. The public health management platform for investigation and pandemic monitoring and early warning can realize the functions of self-detection, automatic uploading of test results, automatic identification of suspected patients, self-positioning of suspected patients, continuous tracking of suspected patients, etc., providing the necessary technical support for the final solution of novel coronavirus pandemic.

It is understood that the detection accuracy rate of the system has reached 70%, and the system has been researched and developed, and it will be expected to enter clinical application on a large scale.